Latest Past Events

Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR)

FDA CDER Office of Pharmaceutical Quality is offering a five-hour webinar to discuss reporting requirements and expectations for Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR). The statutory reporting requirements are found in 21 CFR 314.81 (for FAR) and 21 CFR 600.14 (for BPDR). FDA will share how it assesses these reports and

VRBPAC Meeting on Pfizer’s ABRYSVO Respiratory Syncytial Virus Vaccine

Vaccines and Related Biological Products Advisory Committee May 18, 2023 Meeting Announcement On 18 May 2023, the committee will meet in open session to discuss and make recommendations on the safety and effectiveness of ABRYSVO (Respiratory Syncytial Virus Vaccine), manufactured by Pfizer Inc., with a requested indication, in Biologics License Application (BLA) 125768 (STN 125768/0),

Prioritizing Actions for Epidemic and Pandemic Preparedness

The Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium will be held 18 May 2023. This is the second of two sessions. The purpose of this symposium is to convene global health planning stakeholders, including those in government and academia, and across health- and non-health sectors, to strengthen the capacity for evidence-based prioritization of global